CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies

S. Nishino, T. Kanbayashi, N. Fujiki, M. Uchino, B. Ripley, M. Watanabe, G. J. Lammers, H. Ishiguro, S. Shoji, Y. Nishida, S. Overeem, I. Toyoshima, Y. Yoshida, T. Shimizu, Shahrad Taheri, E. Mignot

Research output: Contribution to journalArticle

73 Citations (Scopus)


CSF hypocretin-1 was measured in 28 Guillain-Barré syndrome (GBS), 12 Miller-Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (<100 pg/mL). Hypocretin-1 levels were moderately reduced in an additional 11 GBS, 5 Miller-Fisher syndrome, and 1 CIDP subject. Low levels in GBS occurred early in the disease and were associated with upper CNS level abnormalities.

Original languageEnglish
Pages (from-to)823-825
Number of pages3
Issue number6
Publication statusPublished - 23 Sep 2003
Externally publishedYes


ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Nishino, S., Kanbayashi, T., Fujiki, N., Uchino, M., Ripley, B., Watanabe, M., Lammers, G. J., Ishiguro, H., Shoji, S., Nishida, Y., Overeem, S., Toyoshima, I., Yoshida, Y., Shimizu, T., Taheri, S., & Mignot, E. (2003). CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology, 61(6), 823-825.